Persistent URL of this record https://hdl.handle.net/1887/103667
In Collections
This item can be found in the following collections:
![Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
- All authors
- Nam, J.L.; Villeneuve, E.; Hensor, E.M.A.; Conaghan, P.G.; Keen, H.I.; Buch, M.H.; Gough, A.K.; Green, M.J.; Helliwell, P.S.; Keenan, A.M.; Morgan, A.W.; Quinn, M.; Reece, R.; Heijde, D.M. van der; Wakefield, R.J.; Emery, P.
- Date
- 2014-01-31
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 73
- Issue
- 1
- Pages
- 75 - 85